175 related articles for article (PubMed ID: 28987389)
41. Clinical Outcome of ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Patients with De Novo EGFR or KRAS Co-Mutations Receiving Tyrosine Kinase Inhibitors (TKIs).
Schmid S; Gautschi O; Rothschild S; Mark M; Froesch P; Klingbiel D; Reichegger H; Jochum W; Diebold J; Früh M
J Thorac Oncol; 2017 Apr; 12(4):681-688. PubMed ID: 28007627
[TBL] [Abstract][Full Text] [Related]
42. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC
Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226
[TBL] [Abstract][Full Text] [Related]
43. Lung cancer in never-smokers.
Planchard D; Besse B
Eur Respir J; 2015 May; 45(5):1214-7. PubMed ID: 25931484
[No Abstract] [Full Text] [Related]
44. Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.
Choi CM; Kim MY; Hwang HJ; Lee JB; Kim WS
Radiology; 2015 Apr; 275(1):272-9. PubMed ID: 25575117
[TBL] [Abstract][Full Text] [Related]
45. Correlation of cytomorphology and molecular findings in EGFR+, KRAS+, and ALK+ lung carcinomas.
Li Z; Dacic S; Pantanowitz L; Khalbuss WE; Nikiforova MN; Monaco SE
Am J Clin Pathol; 2014 Mar; 141(3):420-8. PubMed ID: 24515771
[TBL] [Abstract][Full Text] [Related]
46. Association between environmental tobacco smoke exposure and risk of type 2 diabetes mellitus in Chinese female never smokers: A population-based cohort study.
Huang C; Chen G; Zhang M; Lu Y; Hua Y; Hu Y; Jin J; Zhou J; Bian Z; Guo Y; Li L; Chen Z; Zhang J
J Diabetes; 2020 Apr; 12(4):339-346. PubMed ID: 31642603
[TBL] [Abstract][Full Text] [Related]
47. Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma.
Park J; Kobayashi Y; Urayama KY; Yamaura H; Yatabe Y; Hida T
PLoS One; 2016; 11(8):e0161081. PubMed ID: 27518729
[TBL] [Abstract][Full Text] [Related]
48. Lung cancer in never-smokers: a case-control study in a radon-prone area (Galicia, Spain).
Torres-Durán M; Ruano-Ravina A; Parente-Lamelas I; Leiro-Fernández V; Abal-Arca J; Montero-Martínez C; Pena-Álvarez C; González-Barcala FJ; Castro-Añón O; Golpe-Gómez A; Martínez C; Mejuto-Martí MJ; Fernández-Villar A; Barros-Dios JM
Eur Respir J; 2014 Oct; 44(4):994-1001. PubMed ID: 25034571
[TBL] [Abstract][Full Text] [Related]
49. A biomarker of exposure to environmental tobacco smoke (ETS) and Ernst Wynder's opinion about ETS and lung cancer.
Hecht SS
Prev Med; 2006 Oct; 43(4):256-60. PubMed ID: 16997360
[TBL] [Abstract][Full Text] [Related]
50. Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT.
Choi H; Paeng JC; Kim DW; Lee JK; Park CM; Kang KW; Chung JK; Lee DS
Lung Cancer; 2013 Mar; 79(3):242-7. PubMed ID: 23261227
[TBL] [Abstract][Full Text] [Related]
51. Passive smoking exposure is associated with increased risk of COPD in never smokers.
Hagstad S; Bjerg A; Ekerljung L; Backman H; Lindberg A; Rönmark E; Lundbäck B
Chest; 2014 Jun; 145(6):1298-1304. PubMed ID: 24356778
[TBL] [Abstract][Full Text] [Related]
52. Genotoxicity of environmental tobacco smoke: a review.
Husgafvel-Pursiainen K
Mutat Res; 2004 Nov; 567(2-3):427-45. PubMed ID: 15572289
[TBL] [Abstract][Full Text] [Related]
53. Environmental tobacco smoke exposure and diabetes in adult never-smokers.
Eze IC; Schaffner E; Zemp E; von Eckardstein A; Turk A; Bettschart R; Schindler C; Probst-Hensch N
Environ Health; 2014 Sep; 13():74. PubMed ID: 25253088
[TBL] [Abstract][Full Text] [Related]
54. Evidence that the lung Adenocarcinoma EML4-ALK fusion gene is not caused by exposure to secondhand tobacco smoke during childhood.
Ryan BM; Wang Y; Jen J; Yi ES; Olivo-Marston S; Yang P; Harris CC
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1432-1434. PubMed ID: 24755712
[TBL] [Abstract][Full Text] [Related]
55. Exposure to environmental tobacco smoke and risk of adenocarcinoma of the lung.
Boffetta P; Ahrens W; Nyberg F; Mukeria A; Brüske-Hohlfeld I; Fortes C; Constantinescu V; Simonato L; Batura-Gabryel H; Lea S; Gaborieau V; Benhamou S
Int J Cancer; 1999 Nov; 83(5):635-9. PubMed ID: 10521800
[TBL] [Abstract][Full Text] [Related]
56. EGFR somatic mutations in lung tumors: radon exposure and passive smoking in former- and never-smoking U.S. women.
Taga M; Mechanic LE; Hagiwara N; Vähäkangas KH; Bennett WP; Alavanja MC; Welsh JA; Khan MA; Lee A; Diasio R; Edell E; Bungum A; Jang JS; Yang P; Jen J; Harris CC
Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):988-92. PubMed ID: 22523180
[TBL] [Abstract][Full Text] [Related]
57. Exposure to environmental tobacco smoke and the risk of heart attack.
Muscat JE; Wynder EL
Int J Epidemiol; 1995 Aug; 24(4):715-9. PubMed ID: 8550268
[TBL] [Abstract][Full Text] [Related]
58. Environmental tobacco smoke and lung cancer: a case-control study in Germany.
Kreuzer M; Krauss M; Kreienbrock L; Jöckel KH; Wichmann HE
Am J Epidemiol; 2000 Feb; 151(3):241-50. PubMed ID: 10670548
[TBL] [Abstract][Full Text] [Related]
59. Childhood exposure to secondhand smoke and functional mannose binding lectin polymorphisms are associated with increased lung cancer risk.
Olivo-Marston SE; Yang P; Mechanic LE; Bowman ED; Pine SR; Loffredo CA; Alberg AJ; Caporaso N; Shields PG; Chanock S; Wu Y; Jiang R; Cunningham J; Jen J; Harris CC
Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3375-83. PubMed ID: 19959685
[TBL] [Abstract][Full Text] [Related]
60. GST-omega genes interact with environmental tobacco smoke on adult level of lung function.
de Jong K; Boezen HM; Hacken NH; Postma DS; Vonk JM;
Respir Res; 2013 Aug; 14(1):83. PubMed ID: 23937118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
